These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
227 related articles for article (PubMed ID: 24439168)
21. Association and expression analyses with single-nucleotide polymorphisms in TOMM40 in Alzheimer disease. Cruchaga C; Nowotny P; Kauwe JS; Ridge PG; Mayo K; Bertelsen S; Hinrichs A; Fagan AM; Holtzman DM; Morris JC; Goate AM; Arch Neurol; 2011 Aug; 68(8):1013-9. PubMed ID: 21825236 [TBL] [Abstract][Full Text] [Related]
22. A TOMM40 variable-length polymorphism predicts the age of late-onset Alzheimer's disease. Roses AD; Lutz MW; Amrine-Madsen H; Saunders AM; Crenshaw DG; Sundseth SS; Huentelman MJ; Welsh-Bohmer KA; Reiman EM Pharmacogenomics J; 2010 Oct; 10(5):375-84. PubMed ID: 20029386 [TBL] [Abstract][Full Text] [Related]
23. APOE ε4-TOMM40 '523 haplotypes and the risk of Alzheimer's disease in older Caucasian and African Americans. Yu L; Lutz MW; Wilson RS; Burns DK; Roses AD; Saunders AM; Yang J; Gaiteri C; De Jager PL; Barnes LL; Bennett DA PLoS One; 2017; 12(7):e0180356. PubMed ID: 28672022 [TBL] [Abstract][Full Text] [Related]
24. Associations between TOMM40 Poly-T Repeat Variants and Dementia in Cases with Parkinsonism. Lindqvist D; Prokopenko I; Londos E; Middleton L; Hansson O J Parkinsons Dis; 2016; 6(1):99-108. PubMed ID: 26756745 [TBL] [Abstract][Full Text] [Related]
25. A TOMM40/APOE allele encoding APOE-E3 predicts high likelihood of late-onset Alzheimer's disease in autopsy cases. Soyal SM; Kwik M; Kalev O; Lenz S; Zara G; Strasser P; Patsch W; Weis S Mol Genet Genomic Med; 2020 Aug; 8(8):e1317. PubMed ID: 32472747 [TBL] [Abstract][Full Text] [Related]
26. Genotypic Effects of the TOMM40'523 Variant and APOE on Longitudinal Cognitive Change over 4 Years: The TOMMORROW Study. Zou H; Luo S; Liu H; Lutz MW; Bennett DA; Plassman BL; Welsh-Bohmer KA J Prev Alzheimers Dis; 2023; 10(4):886-894. PubMed ID: 37874111 [TBL] [Abstract][Full Text] [Related]
27. TOMM40 polymorphisms in Italian Alzheimer's disease and frontotemporal dementia patients. Bagnoli S; Piaceri I; Tedde A; Bessi V; Bracco L; Sorbi S; Nacmias B Neurol Sci; 2013 Jun; 34(6):995-8. PubMed ID: 23546992 [TBL] [Abstract][Full Text] [Related]
28. A homopolymer polymorphism in the TOMM40 gene contributes to cognitive performance in aging. Hayden KM; McEvoy JM; Linnertz C; Attix D; Kuchibhatla M; Saunders AM; Lutz MW; Welsh-Bohmer KA; Roses AD; Chiba-Falek O Alzheimers Dement; 2012 Sep; 8(5):381-8. PubMed ID: 22863908 [TBL] [Abstract][Full Text] [Related]
29. Characterization of the poly-T variant in the TOMM40 gene in diverse populations. Linnertz C; Saunders AM; Lutz MW; Crenshaw DM; Grossman I; Burns DK; Whitfield KE; Hauser MA; McCarthy JJ; Ulmer M; Allingham R; Welsh-Bohmer KA; Roses AD; Chiba-Falek O PLoS One; 2012; 7(2):e30994. PubMed ID: 22359560 [TBL] [Abstract][Full Text] [Related]
30. TOMM40 and APOE variants synergistically increase the risk of Alzheimer's disease in a Chinese population. Zhu Z; Yang Y; Xiao Z; Zhao Q; Wu W; Liang X; Luo J; Cao Y; Shao M; Guo Q; Ding D Aging Clin Exp Res; 2021 Jun; 33(6):1667-1675. PubMed ID: 32725468 [TBL] [Abstract][Full Text] [Related]
31. Association of TOMM40 polymorphisms with late-onset Alzheimer's disease in a Northern Han Chinese population. Ma XY; Yu JT; Wang W; Wang HF; Liu QY; Zhang W; Tan L Neuromolecular Med; 2013 Jun; 15(2):279-87. PubMed ID: 23288655 [TBL] [Abstract][Full Text] [Related]
33. A TOMM40 poly-T variant modulates gene expression and is associated with vocabulary ability and decline in nonpathologic aging. Payton A; Sindrewicz P; Pessoa V; Platt H; Horan M; Ollier W; Bubb VJ; Pendleton N; Quinn JP Neurobiol Aging; 2016 Mar; 39():217.e1-7. PubMed ID: 26742953 [TBL] [Abstract][Full Text] [Related]
34. TOMM40 and APOE Gene Expression and Cognitive Decline in Japanese Alzheimer's Disease Subjects. Mise A; Yoshino Y; Yamazaki K; Ozaki Y; Sao T; Yoshida T; Mori T; Mori Y; Ochi S; Iga JI; Ueno SI J Alzheimers Dis; 2017; 60(3):1107-1117. PubMed ID: 28984592 [TBL] [Abstract][Full Text] [Related]
35. Cerebrospinal fluid cortisol concentrations in healthy elderly are affected by both APOE and TOMM40 variants. Bruno D; Nierenberg JJ; Ritchie JC; Lutz MW; Pomara N Psychoneuroendocrinology; 2012 Mar; 37(3):366-71. PubMed ID: 21803501 [TBL] [Abstract][Full Text] [Related]
37. Neuropathologic features of TOMM40 '523 variant on late-life cognitive decline. Yu L; Lutz MW; Farfel JM; Wilson RS; Burns DK; Saunders AM; De Jager PL; Barnes LL; Schneider JA; Bennett DA Alzheimers Dement; 2017 Dec; 13(12):1380-1388. PubMed ID: 28624335 [TBL] [Abstract][Full Text] [Related]
38. The effects of PPARγ on the regulation of the TOMM40-APOE-C1 genes cluster. Subramanian S; Gottschalk WK; Kim SY; Roses AD; Chiba-Falek O Biochim Biophys Acta Mol Basis Dis; 2017 Mar; 1863(3):810-816. PubMed ID: 28065845 [TBL] [Abstract][Full Text] [Related]
40. Therapeutic considerations for APOE and TOMM40 in Alzheimers disease: A tribute to Allen Roses MD. Sabbagh MN; Pope E; Cordes L; Shi J; DeCourt B Expert Opin Investig Drugs; 2021 Jan; 30(1):39-44. PubMed ID: 33455481 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]